Kazuma Nakagawa1, Alexandra Galati2, Deborah Taira Juarez3. 1. Neuroscience Institute, The Queen's Medical Center, Honolulu, HI, USA; John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA. Electronic address: kazuma.nakagawa@hawaii.edu. 2. John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA. 3. Daniel K. Inouye College of Pharmacy, University of Hawaii, Hilo, HI, USA.
Abstract
BACKGROUND: Currently, intracerebral hemorrhage (ICH) patients from neighbor islands are air transported to a higher-level facility on Oahu with neuroscience expertise. However, the majority of them do not receive subspecialized neurosurgical procedures (SNP) upon transfer. Hence, their transfer may potentially be considered as excess cost. METHODS: Consecutive ICH patients hospitalized at a tertiary center on Oahu between 2006 and 2013 were studied. Subspecialized neurosurgical procedure was defined as any neurosurgical procedure or conventional cerebral angiogram. Total excess cost was estimated as the cost of interisland transfer multiplied by the number of interisland transfer patients who did not receive any SNP. RESULTS: Among a total of 825 patients, 100 patients (12%) were transferred from the neighbor islands. Among the neighbor-island patients, 69 patients (69%) did not receive SNP, which translates to $1035000 of excess cost over an 8-year period (approximately $129375/y). Multivariable analyses showed age (odds ratio [OR], 0.95; 95% confidence interval [CI]: 0.94-0.96), lack of hypertension (OR, 1.62; 95% CI: 1.002-2.61), initial Glasgow Coma Scale (OR, 0.94; 95% CI: 0.89-0.98), lobar hemorrhage (OR, 2.74; 95% CI: 1.59-4.71), cerebellar hemorrhage (OR, 5.47; 95% CI: 2.78-10.76), primary intraventricular hemorrhage (OR, 4.40; 95% CI: 1.77-10.94), and any intraventricular hemorrhage (OR, 2.47l 95% CI: 1.53-3.97) to be independent predictors of receiving SNP. CONCLUSION: Approximately two-thirds of ICH patients who were air transferred did not receive SNP. Further study is needed to assess the cost-effectiveness of creating a triage algorithm to optimally select ICH patients who would benefit from air transport to a higher-level facility.
BACKGROUND: Currently, intracerebral hemorrhage (ICH) patients from neighbor islands are air transported to a higher-level facility on Oahu with neuroscience expertise. However, the majority of them do not receive subspecialized neurosurgical procedures (SNP) upon transfer. Hence, their transfer may potentially be considered as excess cost. METHODS: Consecutive ICHpatients hospitalized at a tertiary center on Oahu between 2006 and 2013 were studied. Subspecialized neurosurgical procedure was defined as any neurosurgical procedure or conventional cerebral angiogram. Total excess cost was estimated as the cost of interisland transfer multiplied by the number of interisland transfer patients who did not receive any SNP. RESULTS: Among a total of 825 patients, 100 patients (12%) were transferred from the neighbor islands. Among the neighbor-island patients, 69 patients (69%) did not receive SNP, which translates to $1035000 of excess cost over an 8-year period (approximately $129375/y). Multivariable analyses showed age (odds ratio [OR], 0.95; 95% confidence interval [CI]: 0.94-0.96), lack of hypertension (OR, 1.62; 95% CI: 1.002-2.61), initial Glasgow Coma Scale (OR, 0.94; 95% CI: 0.89-0.98), lobar hemorrhage (OR, 2.74; 95% CI: 1.59-4.71), cerebellar hemorrhage (OR, 5.47; 95% CI: 2.78-10.76), primary intraventricular hemorrhage (OR, 4.40; 95% CI: 1.77-10.94), and any intraventricular hemorrhage (OR, 2.47l 95% CI: 1.53-3.97) to be independent predictors of receiving SNP. CONCLUSION: Approximately two-thirds of ICHpatients who were air transferred did not receive SNP. Further study is needed to assess the cost-effectiveness of creating a triage algorithm to optimally select ICHpatients who would benefit from air transport to a higher-level facility.
Authors: Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo Journal: Stroke Date: 2010-07-22 Impact factor: 7.914
Authors: A David Mendelow; Barbara A Gregson; Helen M Fernandes; Gordon D Murray; Graham M Teasdale; D Terence Hope; Abbas Karimi; M Donald M Shaw; David H Barer Journal: Lancet Date: 2005 Jan 29-Feb 4 Impact factor: 79.321
Authors: Charlotte Jj van Asch; Merel Ja Luitse; Gabriël Je Rinkel; Ingeborg van der Tweel; Ale Algra; Catharina Jm Klijn Journal: Lancet Neurol Date: 2010-01-05 Impact factor: 44.182
Authors: Matthew B Maas; Neil F Rosenberg; Adam R Kosteva; Rebecca M Bauer; James C Guth; Eric M Liotta; Shyam Prabhakaran; Andrew M Naidech Journal: Neurology Date: 2013-06-05 Impact factor: 9.910
Authors: A David Mendelow; Barbara A Gregson; Elise N Rowan; Gordon D Murray; Anil Gholkar; Patrick M Mitchell Journal: Lancet Date: 2013-05-29 Impact factor: 79.321
Authors: Farhaan S Vahidy; Ellie G Meyer; Arvind B Bambhroliya; Jennifer R Meeks; Charles E Begley; Tzu-Ching Wu; Jon E Tyson; Charles C Miller; Ritvij Bowry; Wamda O Ahmed; Gretchel A Gealogo; Louise D McCullough; Steven Warach; Sean I Savitz Journal: BMC Neurol Date: 2018-03-21 Impact factor: 2.474
Authors: Kori Sauser Zachrison; Emily Aaronson; Sadiqa Mahmood; Jonathan Rosand; Anand Viswanathan; Lee H Schwamm; Joshua N Goldstein Journal: Stroke Vasc Neurol Date: 2019-11-28